Clinical Trial Update: AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating AV2 Antiviral Spray versus placebo for genital human papillomavirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Human Papillomavirus Infection

Drugs mentioned

• AV2 Antiviral Spray

Snippet

Sponsor: Cesa Projects International | Conditions: Genital Human Papilloma Virus Infection | Phase 2 | Status: UNKNOWN